Equity Capital Markets

Company · CIK 1731831

Eidos Therapeutics, Inc.

CIK1731831 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
Listedno ticker on SEC record today
First annual or quarterly report2018-08-07

Offerings

2 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-232999
ShelfEffective
 2019-08-022021-01-273
333-225235
IPOFinal prospectus
 2018-05-252018-06-215

Filings

9
FiledFilingRegistrationAccession
2021-01-27EFFECTDeclared effective 333-2329999999999995-21-000293
2019-08-29EFFECTDeclared effective 333-2329999999999995-19-002009
2019-08-02S-3Shelf registered 333-2329990001193125-19-212159
2018-06-21424B4Final prospectus 333-2252350001193125-18-199665
2018-06-19EFFECTDeclared effective 333-2252359999999995-18-001537
2018-06-15S-1/AAmendment 333-2252350001193125-18-194150
2018-06-08S-1/AAmendment 333-2252350001193125-18-187299
2018-05-25S-1Registration filed 333-2252350001193125-18-175445
2018-03-23DRSDraft made public 377-019830000950123-18-003103

All filings of this company · CSV